Revealing the indispensable role of the RFamide functionality using a novel acid labile benzofuranone based amine (ALBA) linker

dc.contributor.authorMudd, Gemma
dc.contributor.authorHendrikse, Megan
dc.contributor.authorShave, Steven
dc.contributor.authorHouston, Douglas R.
dc.contributor.authorMillar, Robert P.
dc.contributor.authorAuer, Manfred
dc.date.accessioned2024-06-25T06:26:43Z
dc.date.available2024-06-25T06:26:43Z
dc.date.issued2024-04
dc.descriptionDATA AVAILABILITY STATEMENT : The data that support the findings of this study are available from the corresponding author upon reasonable request.en_US
dc.descriptionThis article also appears in: Andrea Vasella 80th Birthday Biochemistry and Medicinal Chemistry Organic and Organometallic Chemistry.en_US
dc.description.abstractThe RFamide family of peptides represents an important class of GPCR ligand neuropeptides covering a wide range of biological functions. While many analogues of the highly conserved C-terminal RFamide motif within this peptide class have been synthesized and their functional significance elucidated, additional exploration of the structure activity relationship is of value. We have developed a novel linker for solid phase peptide synthesis (SPPS) which is able to anchor amine functionalised compounds for further elaboration. The acid labile benzofuranone based amine (ALBA) linker (5-(3-aminopropylcarbamoyl)-2-[[tert-butyl(diphenyl)silyl]oxymethyl]benzoic acid) is compatible with Fmoc based SPPS and has two cleavage modes. As a proof of concept, the ALBA linker was used to successfully synthesise a novel analogue of Kisspeptin 10, the natural ligand for GPCR54, whereby the natural RFamide motif was replaced with an RFamine. Biological evaluation of the amine-containing analogue revealed that the group is not compatible with receptor activation.en_US
dc.description.departmentImmunologyen_US
dc.description.librarianhj2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sponsorshipThis work was completed as part of a BioSKAPE studentship funded by SULSA, the BBSRC and Pfizer Ltd. Support is also acknowledged from the Scottish Universities Life Sciences Alliance (SULSA) and the Medical Research Council (MRC9) Strategic Grant.en_US
dc.description.urihttps://onlinelibrary.wiley.com/journal/15222675en_US
dc.identifier.citationMudd, G., Hendrikse, M., Shave, S. et al. 2024, 'Revealing the indispensable role of the RFamide functionality using a novel acid labile benzofuranone based amine (ALBA) linker', Helvetica Chimica Acta, vol. 107, no. 4, art. e202300204, pp. 1-7, doi : 10.1002/hlca.202300204.en_US
dc.identifier.issn0018-019X (print)
dc.identifier.issn1522-2675 (online)
dc.identifier.other10.1002/hlca.202300204
dc.identifier.urihttp://hdl.handle.net/2263/96632
dc.language.isoenen_US
dc.publisherWileyen_US
dc.rights© 2024 The Authors. Helvetica Chimica Acta published by Wiley-VHCA AG.en_US
dc.subjectCleavable linkeren_US
dc.subjectKisspeptinen_US
dc.subjectGPR54en_US
dc.subjectG-protein coupled receptor (GPCR)en_US
dc.subjectRFamideen_US
dc.subjectSolid phase peptide synthesis (SPPS)en_US
dc.subjectAcid labile benzofuranone based amine (ALBA)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleRevealing the indispensable role of the RFamide functionality using a novel acid labile benzofuranone based amine (ALBA) linkeren_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Mudd_Revealing_2024.pdf
Size:
7.62 MB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Mudd_RevealingSuppInfo_2024.pdf
Size:
934.54 KB
Format:
Adobe Portable Document Format
Description:
Supporting Information

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: